Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

October 26, 2006 | Comments Off on Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

Clinical Cancer Research. Vol. 12, 5944-5950, October 15, 2006. [Link] Ben Davidson1, Zhen Zhang2, Lilach Kleinberg1, Mei Li3, Vivi Ann Flørenes1, Tian-Li Wang3 and Ie-Ming Shih2,3 Authors’ Affiliations: 1 Department…

Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma

October 26, 2006 | Comments Off on Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma

Clinical Cancer Research. Vol. 12, 6133-6143, October 15, 2006. [Link] Enrico P. Spugnini1, Irene Cardillo2, Alessandra Verdina2, Stefania Crispi5, Silvia Saviozzi8, Raffaele Calogero8, Angela Nebbioso6, Lucia Altucci6, Giancarlo Cortese1, Rossella…

Malignant pleural mesothelioma: A new standard of care

October 25, 2006 | Comments Off on Malignant pleural mesothelioma: A new standard of care

Lung Cancer. 2006 Dec;54 Suppl 2:S9-S14. Epub 2006 Oct 23. [Link] Stahel RA. Clinic and Policlinic for Oncology/Department of Internal Medicine, University Hospital, Zurich, Switzerland. Abstract Malignant pleural mesothelioma (MPM)…

Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus

October 25, 2006 | Comments Off on Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus

The Journal of Thoracic Cardiovascular Surgery. 2006 Nov;132(5):1179-88. [Link] Adusumilli PS, Eisenberg DP, Stiles BM, Chung S, Chan MK, Rusch VW, Fong Y. Department of Surgery, Memorial Sloan-Kettering Cancer Center,…

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

October 24, 2006 | Comments Off on What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

Human Pathology. 2006 Oct 20; [Epub ahead of print] [Link] Nelson G. Ordóñez MDa aThe University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Received 4 May 2006; …

Feasibility of Boron Neutron Capture Therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis

October 24, 2006 | Comments Off on Feasibility of Boron Neutron Capture Therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis

International Journal of Radiation Oncology, Biology, Physics. 2006 Oct 20; [Epub ahead of print] [Link] Suzuki M, Sakurai Y, Masunaga S, Kinashi Y, Nagata K, Maruhashi A, Ono K. Particle…

EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

October 20, 2006 | Comments Off on EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

Lung Cancer, Volume 54, Issue 3, Pages 399-407 J.G. Edwardsa,b, D.E.B. Swinsona, J.L. Jonesc, D.A. Wallerb, K.J. O’Byrned a Department of Oncology, University of Leicester, Leicester, United Kingdom b Department…

Sex difference in diffuse malignant peritoneal mesothelioma

October 19, 2006 | Comments Off on Sex difference in diffuse malignant peritoneal mesothelioma

British Journal of Surgery. 2006 Oct 18; [Epub ahead of print] [Link] Yan TD, Popa E, Brun EA, Cerruto CA, Sugarbaker PH. Washington Cancer Institute, Washington, DC, USA. Abstract Background:…

Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach

October 17, 2006 | Comments Off on Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach

Seminars in Diagnostic Pathology. 2006 Feb;23(1):4-14. [Link] Kradin RL, Mark EJ. Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA. rkradin@partners.org Abstract This paper examines the spectrum of challenges…

The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion

October 17, 2006 | Comments Off on The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion

Seminars in Diagnostic Pathology. 2006 Feb;23(1):15-9. [Link] Li Q, Bavikatty N, Michael CW. Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA. Abstract Background: Distinguishing metastatic squamous cell…

Categories